Revive Therapeutics Ltd (RVVTF)

[ReikoBlack]

This is the list of companies to be included in Horizons’ Psychedelics ETF.

Johnson & Johnson (JNJ)
AbbVie Inc (ABBV)
COMPASS Pathways (CMPS)
Field Trip Health (FTRP)
MindMed (MMED)
Greenbrook TMS Inc (GTMS)
Entheon Biomedical (ENBI)
Seelos Therapeutics (SEEL)
Cybin (CYBN)
Mind Cure Health (MCUR)
Havn Life Sciences (HAVN)
Numinus (NUMI)
Mydecine Innovations (MYCO)
Nova Mentis (NOVA)
Psyched Wellness (PSYC)
Revive Therapeutics (RVV)
Red Light Holland (TRIP)


Along with MindMed(MMED), Numinus(NUMI), Cybin(CYBN), and Revive Therapeutics(RVVTF)…

Field Trip Health(FTRP), Mind Cure Health(MCUR), Havn Life Sciences(HAVN), Mydecine Innovations(MYCO), Psyched Wellness(PSYC), and Red Light Holland(TRIP) have also announced bought deal offerings over the past weeks…2 of those deals being announced today after the market closed.

I posted this earlier today.

((“Taken from a post on Yahoo.

"Is it too far fetched to think these public offerings are related to the upcoming etf!? Mmed, numi, cybin, and now Rvv have gotten millions in $$ in exchange for shares in the past 2ish weeks."”))
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161074260

==================================================================

I concur with the above post from Yahoo and believe the bought deal offering has more do to with the upcoming ETF than RVVTF simply trying to raise capital at this time. And, I believe RVVTF was probably approached to do the offering.

I looked into the other companies mentioned in the post from Yahoo.

MindMed (MMED) closed on a bought deal offering on January 7, 2021. Canaccord Genuity Corp was the lead Underwriter along with Eight Capital and CIBC Capital Markets.
https://mindmed.co/news/press-release/mindmed-closes-upsized-financing-of-cad-92-1m-usd-72-7m-to-meet-high-investor-demand/

Numinus Wellness Inc (NUMI) closed on a bought deal offering on December 29, 2020. Canaccord Genuity Corp. and Eight Capital were the Underwriters.
https://numinus.ca/investors/news-release/numinus-announces-closing-of-17-million-bought-deal-offering-including-full-exercise-of-over-allotment-option

Cybin Inc (CYBN) announced a bought deal offering on January 18, 2021. Canaccord Genuity Corp is the lead Underwriter.
https://www.newswire.ca/news-releases/cybin-announces-cdn-20-million-bought-deal-offering-872605166.html

Revive Therapeutics - Co-Underwriters for the recent bought deal offering are Canaccord Genuity Corp. and Leede Jones Gable Inc.